Header Logo

Connection

SANDEEP AGARWAL to Ustekinumab

Back to Details
This is a "connection" page, showing publications SANDEEP AGARWAL has written about Ustekinumab.
SANDEEP AGARWAL
Connection Strength
0.140
Ustekinumab
  1. A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Ann Rheum Dis. 2017 May; 76(5):831-839.
    View in: PubMed
    Score: 0.140
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.